111 related articles for article (PubMed ID: 12937898)
1. Analysis of costimulation by 4-1BBL, CD40L, and B7 in graft rejection by gene expression profiles.
DeFina R; Christopher K; He H; Mandelbrot D; Gu Y; Finn P; Perkins DL
J Mol Med (Berl); 2003 Oct; 81(10):655-63. PubMed ID: 12937898
[TBL] [Abstract][Full Text] [Related]
2. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.
Asai T; Choi BK; Kwon PM; Kim WY; Kim JD; Vinay DS; Gebhardt BM; Kwon BS
Immunology; 2007 Jul; 121(3):349-58. PubMed ID: 17376197
[TBL] [Abstract][Full Text] [Related]
3. Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival.
Cho HR; Kwon B; Yagita H; La S; Lee EA; Kim JE; Akiba H; Kim J; Suh JH; Vinay DS; Ju SA; Kim BS; Mittler RS; Okumura K; Kwon BS
Transpl Int; 2004 Aug; 17(7):351-61. PubMed ID: 15349720
[TBL] [Abstract][Full Text] [Related]
4. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection.
Hancock WW; Sayegh MH; Zheng XG; Peach R; Linsley PS; Turka LA
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):13967-72. PubMed ID: 8943044
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy using adenoviral vector encoding 4-1BBIg gene significantly prolonged murine cardiac allograft survival.
Huang BJ; Yin H; Huang YF; Xu JF; Xiong P; Feng W; Zheng F; Xu Y; Fang M; Gong FL
Transpl Immunol; 2006 Aug; 16(2):88-94. PubMed ID: 16860710
[TBL] [Abstract][Full Text] [Related]
6. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
[TBL] [Abstract][Full Text] [Related]
7. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
Burrell BE; Lu G; Li XC; Bishop DK
J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
[TBL] [Abstract][Full Text] [Related]
8. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA; Wu Z; Zheng XG; Sharpe AH; Sayegh MH; Turka LA
J Immunol; 1999 Feb; 162(4):1947-51. PubMed ID: 9973463
[TBL] [Abstract][Full Text] [Related]
9. Costimulation of CD28- T lymphocytes by 4-1BB ligand.
DeBenedette MA; Shahinian A; Mak TW; Watts TH
J Immunol; 1997 Jan; 158(2):551-9. PubMed ID: 8992967
[TBL] [Abstract][Full Text] [Related]
10. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection.
Guillonneau C; Louvet C; Renaudin K; Heslan JM; Heslan M; Tesson L; Vignes C; Guillot C; Choi Y; Turka LA; Cuturi MC; Anegon I; Josien R
J Immunol; 2004 Feb; 172(3):1619-29. PubMed ID: 14734743
[TBL] [Abstract][Full Text] [Related]
11. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
12. Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus.
DeBenedette MA; Wen T; Bachmann MF; Ohashi PS; Barber BH; Stocking KL; Peschon JJ; Watts TH
J Immunol; 1999 Nov; 163(9):4833-41. PubMed ID: 10528184
[TBL] [Abstract][Full Text] [Related]
13. Critical, but conditional, role of OX40 in memory T cell-mediated rejection.
Vu MD; Clarkson MR; Yagita H; Turka LA; Sayegh MH; Li XC
J Immunol; 2006 Feb; 176(3):1394-401. PubMed ID: 16424166
[TBL] [Abstract][Full Text] [Related]
14. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
Mandelbrot DA; Oosterwegel MA; Shimizu K; Yamada A; Freeman GJ; Mitchell RN; Sayegh MH; Sharpe AH
J Clin Invest; 2001 Apr; 107(7):881-7. PubMed ID: 11285307
[TBL] [Abstract][Full Text] [Related]
15. New possibilities of therapeutic interventions in transplantation.
Magott-Procelewska M; Klinger M
Ann Transplant; 2004; 9(3):19-24. PubMed ID: 15759542
[TBL] [Abstract][Full Text] [Related]
16. Role of 4-1BB:4-1BB ligand in cancer immunotherapy.
Cheuk AT; Mufti GJ; Guinn BA
Cancer Gene Ther; 2004 Mar; 11(3):215-26. PubMed ID: 14671675
[TBL] [Abstract][Full Text] [Related]
17. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
[TBL] [Abstract][Full Text] [Related]
18. Induction of CD4+CD25+ T cells and control of cardiac allograft rejection by CD40/CD40L costimulatory pathway blockade in mice.
Fu W; Zhu J; Qiu Y; Li W
Transplant Proc; 2013 Mar; 45(2):611-7. PubMed ID: 23498798
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice.
Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R
Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867
[TBL] [Abstract][Full Text] [Related]
20. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo.
Kishimoto K; Dong VM; Issazadeh S; Fedoseyeva EV; Waaga AM; Yamada A; Sho M; Benichou G; Auchincloss H; Grusby MJ; Khoury SJ; Sayegh MH
J Clin Invest; 2000 Jul; 106(1):63-72. PubMed ID: 10880049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
